Federation des caisses Desjardins du Quebec’s Larimar Therapeutics LRMR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.63K	Buy	+2,500	New	+$9.93K	﹤0.01%	2493

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's LRMR Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 2,500 shares worth $7.63K. The stake represents ﹤0.01% of the portfolio and ranks #2493 among its holdings.

163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Federation des caisses Desjardins du Quebec held 2,500 shares of Larimar Therapeutics worth $7.63K as of Q2 2026.
Larimar Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q2 2026.
Larimar Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2493 holding.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.